| Total (N = 901) N (%) or median (IQR) | No PR-BSI (N = 828) N (%) or median (IQR) | PR-BSI (N = 73) N (%) or median (IQR) |
---|---|---|---|
Patients, N | 783 | 713 | 70 |
Sex ratio M/F | 500/401 | 461/367 | 37/33 |
Age (year) | 70.9 (IQR, 59.4–79.8) | 71.0 (IQR, 59.8–80.5) | 69.8 (IQR, 58.8–74.1) |
Body Mass Index (kg/m2) | 24.5 (IQR, 21.2–28.9) | 23.8 (IQR, 20.7–28.1) | 24.4 (IQR, 21.1–28.7) |
Charlson comorbidity index | |||
Main comorbidities | |||
Corticosteroids | 141 (18%) | 112 (16%) | 29 (41%) |
Immunosuppressors | 101 (13%) | 78 (11%) | 23 (33%) |
Solid tumour | 142 (18%) | 129 (18%) | 13 (19%) |
Metastatic solid tumour | 178 (23%) | 151 (21%) | 27 (38%) |
Haematological malignancy | 69 (9%) | 51 (7%) | 18 (26%) |
Leukaemia | 46 (6%) | 36 (5%) | 10 (14%) |
Lymphoma | 23 (3%) | 15 (2%) | 8 (11%) |
PICC lumen | |||
1Â lumen | 712 (79%) | 669 (81%) | 43 (59%) |
2 lumens | 189 (21%) | 159 (19%) | 30 (41%) |
Reason for PICC insertion | |||
Antimicrobial therapy | 408 (45%) | 397 (48%) | 11 (15%) |
Chemotherapy | 240 (27%) | 201 (24%) | 39 (53%) |
Difficult venous access | 154 (17%) | 143 (17%) | 11 (15%) |
Total parenteral nutrition | 52 (6%) | 44 (5%) | 8 (11%) |
Iterative venous access | 47 (5%) | 43 (5%) | 4 (5%) |
Insertion site | |||
Left basilic vein | 470 (52%) | 436 (53%) | 34 (47%) |
Right basilic vein | 135 (15%) | 124 (15%) | 11 (15%) |
Left brachial vein | 209 (24%) | 189 (22%) | 21 (29%) |
Right brachial vein | 72 (8%) | 67 (8%) | 5 (7%) |
Left cephalic vein | 12 (1%) | 10 (1%) | 2 (3%) |
Right cephalic | 1 (< 1%) | 1 (< 1%) | 0 (0%) |
Femoral | 1 (< 1%) | 1 (< 1%) | 0 (0%) |
PICC maintenance (days) | 21 (IQR, 9–43] | 20 (IQR, 9–41] | 30 (IQR, 16–76) |
Reason for PICC removal | |||
End of IV therapy | 529 (59%) | 529 (64%) | 0 (0%) |
Accidental withdrawal | 61 (7%) | 60 (7%) | 1 (1%) |
PR-BSI suspicion | 124 (14%) | 62 (7%) | 62 (85%) |
Positive blood culture | 5 (1%) | 2 (<1%) | 3 (4%) |
Vein thrombosis | 18 (2%) | 17 (2%) | 1 (<1%) |
PICC occlusion | 12 (1%) | 11 (1%) | 1 (<1%) |
Local inflammation | 9 (1%) | 8 (1%) | 1 (<1%) |
Port implantation | 26 (3%) | 25 (3%) | 1 (<1%) |
Death | 117 (13%) | 114 (14%) | 3 (4%) |